ARCHIVES

Unwanted Distinction: MSKCC Bars Zaltrap From Formulary, Triggering Debate Over Drug Pricing

This article is from The Cancer Letter archive.

Vol. 38 No. 41 | November 1, 2012

Download PDF Visit The Full Archive

Related Articles

Researchers Link Cancer Risk And DMPA Birth Control Use

April 27, 2012

DCBDC Advisors Okay New Program In Breast Cancer

July 3, 1992

Construction, Senior Biomedical Service Not In Legislation

November 4, 1988

Missouri Continues Breast Screening, Adds Other Tests

July 9, 1982

Alternating Mammography, MRI Tested For High-Risk Women

January 30, 2009

Cooperative Group Reorganization To Be Offered By DeVita At Clinical Trials Review Next March

October 20, 1978